Enorama Pharma AbOMXSTO: ERMA

ERMA: Net sales rose sharply and losses narrowed as US pouch sales accelerated

· Issued by Enorama Pharma AB

Net sales surged year-over-year, driven by US pouch sales, while operating losses narrowed. Production was stabilized at Habit Factory, new partnerships were formed, and capital was raised to support growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.